Medical Marijuana Inc (OTCMKTS:MJNA) portfolio arm Kannaway recorded 42% sales growth for the period between December 1, 2014 and February 25, 2015. It disclosed that it is included in award category of ‘Start-Up of the Year Award’ for 2014. Its portfolio company, Kannaway, LLC, is an innovative firm that concentrates on hemp lifestyle network marketing so as to provide natural cannabidiol hemp botanical items to customers.
Kannaway acknowledged a letter of intent to be purchased by Medical Marijuana during this period. Medical Marijuana is the first publicly-traded ‘cannabis’ company in the world. The news of acquisition has been a prime reason for the stock run-up in last few months.
The achievements
Medical Marijuana said that Kannaway, LLC achieved impressive revenue during this period. The total count of Brand Ambassadors grew sharply by 64%. In addition, it disclosed that The Academy of Multi-Level Marketing included portfolio firm Kannaway in the list of Start-Up of the Year category award for 2014.
Kevin Thomson, the legal counsel of portfolio firm was acknowledged as Person of the Year 2014 by reputed entity directsellinglive.com. He was even included in category of Advocate of the Year by TAMM.
The significance
Jeff Rogers, the CEO of portfolio firm said that it is a moment of honor to be recognized by TAMM. The prime objective of the company is to spread awareness related with the appropriate use of hemp amongst consumers. The strong measures taken by the company reflects the commitment that the brand ambassadors have towards the company’s objective. The goal of Medical Marijuana’s portfolio entity is to shore up the importance of the revitalization of Hemp in all potential regions.
Stuart Titus of Medical Marijuana said that the team looks forward to extensive growth of the budding global industrial hemp market. In last trading session, the stock of Medical Marijuana declined 2.58% to close at $0.0945.
